t
PATIENT SAFETY
New hub enhances clinical trial capability
NHS Digital is working with the University of Oxford, Microsoft and IBM to develop a hub that aims to revolutionise the way in which clinical trials are delivered – providing foundation services to determine whether a clinical trial is feasible, and to support better planning and delivery of clinical trials in the UK.
NHS DigiTrial, the NHS Health Data Research Hub for Clinical Trials, is one of seven new hubs designed to enable cutting-edge research for health discoveries. Led by Health Data Research UK, they are the first of their kind in the world and aim to improve the lives of people with debilitating conditions by making health data more accessible and user-friendly for research, while maintaining strict controls around data security and privacy. NHS DigiTrial will initially provide a foundation service to return cohort feasibility queries and support patient enrolment and
communication, and long-term follow-up of a cohort. Sarah Wilkinson, CEO of NHS Digital, believes the hub will enable the organisation to strengthen its support for academic research communities and life sciences partners in the extraordinary and vital work they do to develop new treatments. “We are very excited about partnering with the Nuffield Department of Population Health in this work, and delighted to have support, and deep technical expertise from Microsoft and IBM,” She said. “As the primary national data custodian
for the health and care system, NHS Digital’s first and central consideration in all such work is operating within appropriate privacy, security and information governance frameworks, and these will guide the design and delivery of this new service.”
Lowering costs
It is hoped that the hub will contribute to lowering costs of future medical treatment and therapies, and that it will be part of an ecosystem to support life science organisations, attract future inward investment to the UK, and advance and improve vital healthcare research to benefit patients. NHS Digital will lead the consortia and provide the service, with world class system security, to leverage the globally-unique data assets within the NHS. The organisation added that it will ensure strict adherence to information governance standards, patient confidentiality, data protection legislation and upholding patient privacy rights. The Nuffield Department of Population Health at the University of Oxford will provide clinical and trial leadership, building on a proven track record in the safe management of clinical data and in running landmark trials of treatments for heart and other major diseases.
With a clear focus on data security, safety and public involvement, this is an important and exciting next step in the UK’s health data proposition and builds on the fantastic strengths we have across our health service, universities and industry. Martin Landray, Nuffield Department of Population Health
NOVEMBER 2019
“Clinical trials are essential to understand the safety and efficacy of treatments,” said Professor Martin Landray, from the Nuffield Department of Population Health, at the University of Oxford.
“By working closely with patients and the NHS, this new hub seeks to increase opportunities for participation in clinical trials and enhance the quality of the information that they produce. This new digitally-enabled approach will reduce the cost of developing new treatments and improve the quality of information available to patients and their doctors. “With a clear focus on data security, safety and public involvement, this is an important and exciting next step in the UK’s health data proposition and builds on the
WWW.CLINICALSERVICESJOURNAL.COM I 63
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100 |
Page 101 |
Page 102 |
Page 103 |
Page 104
